Chemoinformaics analysis of Butanamide, N-(1,1-dimethylethyl)-3,3-dimethyl-
| Molecular Weight | 171.284 | nRot | 1 |
| Heavy Atom Molecular Weight | 150.116 | nRig | 1 |
| Exact Molecular Weight | 171.162 | nRing | 0 |
| Solubility: LogS | -2.426 | nHRing | 0 |
| Solubility: LogP | 2.638 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.6047 |
| nHD | 1 | BPOL | 22.5053 |
| QED | 0.644 |
| Synth | 2.182 |
| Natural Product Likeliness | -1.077 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.035 |
| CACO-2 | -4.427 |
| MDCK | 0.0000171 |
| BBB | 0.978 |
| PPB | 0.799521 |
| VDSS | 1.188 |
| FU | 0.364174 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.354 |
| CYP2c19-inh | 0.348 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.759 |
| CYP2d6-inh | 0.046 |
| CYP2d6-sub | 0.754 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.313 |
| CL | 5.027 |
| T12 | 0.77 |
| hERG | 0.008 |
| Ames | 0.004 |
| ROA | 0.069 |
| SkinSen | 0.245 |
| Carcinogencity | 0.032 |
| EI | 0.922 |
| Respiratory | 0.071 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.838933 |